Wolverine Asset Management LLC purchased a new position in Intelligent Medicine Acquisition Corp. (NASDAQ:IQMD – Get Rating) in the 4th quarter, HoldingsChannel reports. The fund purchased 10,000 shares of the company’s stock, valued at approximately $99,000.
Separately, Dupont Capital Management Corp acquired a new position in shares of Intelligent Medicine Acquisition in the fourth quarter worth $255,000. Hedge funds and other institutional investors own 25.60% of the company’s stock.
NASDAQ:IQMD opened at $9.97 on Friday. The stock has a fifty day simple moving average of $9.99. Intelligent Medicine Acquisition Corp. has a 52 week low of $9.86 and a 52 week high of $10.93.
Intelligent Medicine Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of life science.
- Get a free copy of the StockNews.com research report on Intelligent Medicine Acquisition (IQMD)
- The Three Most Upgraded Stocks You Can Buy Now
- MarketBeat: Week in Review 5/9 – 5/13
- Is Electronic Arts (NASDAQ: EA) Suddenly A Safe Haven?
- Beyond Meat Stock Value is Improving
- The Travel Sector Is Getting Upgraded
Receive News & Ratings for Intelligent Medicine Acquisition Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intelligent Medicine Acquisition and related companies with MarketBeat.com's FREE daily email newsletter.